MicroRNA-22 negatively regulates LPS-induced inflammatory responses by targeting HDAC6 in macrophages

• Published in: BMB reports Vol. 53; no. 4; pp. 223 - 228
• Main Authors: Youn, Gi Soo, Park, Jong Kook, Lee, Chae Yeon, Jang, Jae Hee, Yun, Sang Ho, Kwon, Hyeok Yil, Choi, Soo Young, Park, Jinseu
• Format: Journal Article
• Language: Korean
• Published: 생화학분자생물학회 30.04.2020
• Subjects: Cytokine; HDAC6; LPS; Macrophages; miR-22; miR-22; Macrophages; HDAC6; LPS; Cytokine
• ISSN: 1976-6696; 1976-670X

Dysregulation of histone deacetylase 6 (HDAC6) can lead to the pathologic states and result in the development of various diseases including cancers and inflammatory diseases. The objective of this study was to elucidate the regulatory role of microRNA-22 (miR-22) in HDAC6-mediated expression of pro-inflammatory cytokines in lipopolysaccharide (LPS)-stimulated macrophages. LPS stimulation induced HDAC6 expression, but suppressed miR-22 expression in macrophages, suggesting possible correlation between HDAC6 and miR-22. Luciferase reporter assays revealed that 3’UTR of HDAC6 was a bona fide target site of miR-22. Transfection of miR-22 mimic significantly inhibited LPS-induced HDAC6 expression, while miR-22 inhibitor further increased LPS-induced HDAC6 expression. LPS-induced activation of NF-κB and AP-1 was inhibited by miR-22 mimic, but further increased by miR-22 inhibitor. LPS-induced expression of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6 was inhibited by miR-22 mimic, but further increased by miR-22 inhibitor. Taken together, these data provide evidence that miR-22 can downregulate LPS-induced expression of pro-inflammatory cytokines via suppression of NF-κB and AP-1 axis by targeting HDAC6 in macrophages. [BMB Reports 2020; 53(4): 223-228]